Lijian Wu

机构：Dana-Farber Cancer Institute · ORCID：0000-0001-6318-380X

发表论文 8 篇 · 总被引 348 次 · h-index 4

代表论文

• Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α (2023 · Cell Metabolism · 被引 281)
• Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells (2025 · Immunity · 被引 33)
• Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial (2026 · Cell · 被引 15)
• CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success (2025 · Cell · 被引 15)
• Perturbation of calreticulin potentiates CD8+ T cell–mediated antitumor immunity (2025 · The Journal of Experimental Medicine · 被引 4)
• Targeting plasticity in the pyrimidine synthesis pathway potentiates macrophage-mediated phagocytosis in pancreatic cancer models (2025 · Journal of Clinical Investigation · 被引 1)